Arsenox 1mg Injection

Arsenox 1mg Injection About

Arsenox Arsenic Trioxide Injection 1 mg/ml is a sterile intravenous anticancer injection indicated for the treatment of Acute Promyelocytic Leukemia (APL) under the supervision of qualified oncology specialists. Manufactured to stringent pharmaceutical quality standards, this injectable formulation ensures high purity, consistent potency, and reliable therapeutic performance.

Suitable for hospitals, oncology centers, government tenders, institutional procurement, pharmaceutical distributors, exporters, and healthcare organizations, Arsenox is supplied in export-quality packaging with complete documentation support. The product is intended strictly for hospital and clinical use and should be administered only by trained healthcare professionals.

Bulk quantities are available for domestic and international B2B buyers.

Powerful Oncology Solution

Arsenox 1mg Injection offers a high-quality and targeted approach to cancer therapy using Arsenic Trioxide. Its pharmaceutical-grade formulation ensures consistent efficacy and reliable performance for hospitals and medical institutions.


Advanced Manufacturing and Quality Standards

Each vial of Arsenox is produced under rigorous GMP protocols in India and undergoes thorough quality control checks. The export-quality packaging reinforces the product's stability and efficacy, making it an excellent choice for healthcare procurement.


Safe and Convenient Handling

Arsenox is designed for easy handling with clear storage guidelines. It should be stored below 25C, away from sunlight, and never frozen. Robust packaging minimizes breakage during transit and ensures product integrity up to patient administration.